I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G44.6 KBInozyme Pharma, Inc.Dec 9, 4:14 PM ET·0001839882-24-044356
- SC 13G/A56.0 KBInozyme Pharma, Inc.Nov 14, 12:19 PM ET·0001580642-24-006952
- SC 13G13.7 KBInozyme Pharma, Inc.Nov 8, 2:17 PM ET·0002012383-24-003528
- 10-Q6.0 MBInozyme Pharma, Inc.Nov 5, 8:33 AM ET·0000950170-24-121090
- 8-K333.2 KBInozyme Pharma, Inc.Nov 5, 8:31 AM ET·0000950170-24-121089
- 8-K220.9 KBInozyme Pharma, Inc.Oct 24, 4:34 PM ET·0000950170-24-117087
- SC 13G13.7 KBInozyme Pharma, Inc.Oct 24, 2:02 PM ET·0002012383-24-002134
- 8-K159.9 KBInozyme Pharma, Inc.Oct 7, 4:33 PM ET·0000950170-24-113241
- 8-K205.0 KBInozyme Pharma, Inc.Aug 6, 4:54 PM ET·0001193125-24-194957
- 10-Q5.7 MBInozyme Pharma, Inc.Aug 6, 8:41 AM ET·0000950170-24-091230
Insiders
10Tickers
No tickers on record
Addresses
business
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
mailing
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
Former Names
- Inozyme Pharma, LLC2017-01-05